Dow Down 0.17% Nasdaq Down 0.28%

Hemispherx Biopharma, Inc. (HEB)

-NYSE MKT
0.32 Up 0.00(0.31%) 4:01PM EDT
|After Hours : 0.33 Up 0.01 (2.77%) 4:48PM EDT - Nasdaq Real Time Price
Prev Close:0.32
Open:0.32
Bid:0.30 x 500
Ask:0.33 x 15000
1y Target Est:3.00
Beta:0.96
Next Earnings Date:N/A
Day's Range:0.30 - 0.32
52wk Range:0.19 - 0.55
Volume:1,085,815
Avg Vol (3m):828,711
Market Cap:60.97M
P/E (ttm):N/A
EPS (ttm):-0.10
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for HEB

Comparison

Symbol% ChgMkt Cap
HEBUp 0.31%60.97M
GILDDown 0.99%160.92B
MRKDown 0.22%171.00B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):330.33
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.11
Quarterly EPS Est (Sep-14) :-0.03
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.12

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Hemispherx Biopharma, Inc., a specialty pharmaceutical company, is engaged in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback